Literature DB >> 6182613

Deaths halt interferon trials in France.

D Dickson.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  1982        PMID: 6182613     DOI: 10.1126/science.6182613

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Reversible cardiomyopathy induced by interferon.

Authors:  M Sonnenblick; D Rosenmann; A Rosin
Journal:  BMJ       Date:  1990-05-05

2.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05

3.  Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.

Authors:  S Martino; V Ratanatharathorn; C Karanes; B A Samal; Y H Sohn; S A Rudnick
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Reversible cardiac arrhythmia in a breast cancer patient treated with recombinant alpha interferon.

Authors:  S Martino; B A Samal; Y H Sahn
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 5.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

6.  Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.

Authors:  G T Budd; R M Bukowski; L Miketo; B Yen-Lieberman; M R Proffitt
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.